Africa: Advances in PrEP Options and HIV Vaccine Research Unveiled at HIVR4P 2024, the 5th HIV Research for Prevention Conference
Lima, Peru — New information from the PURPOSE 2 research of twice-yearly lenacapavir for HIV prevention are among the many ...
